Home » Topics » BioWorld Science

BioWorld Science
RSS

miR-27a-3p is a potential therapeutic target in prostate cancer

Feb. 19, 2020

Bipolar-like behavior key factor found in iPSCs and mice

Feb. 19, 2020

Improvements seen with olipudase alfa in pediatric patients with acid sphingomyelinase deficiency

Feb. 19, 2020

Toll-like receptor 7/8 antagonists identified at Merck KGaA

Feb. 19, 2020

NZP UK, University of Southampton identify FXR agonists

Feb. 19, 2020

City of Hope National Medical Center discovers PARG inhibitors

Feb. 19, 2020

New IDO-1 inhibitors identified at Bristol-Myers Squibb

Feb. 19, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical and collaborators patent BRD4 inhibitors

Feb. 19, 2020

ATLAS study of rucaparib in mUC suspended due to lack of activity

Feb. 19, 2020

AABH as new predictive biomarker for early diagnosis of prostate cancer

Feb. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...